|Articles|October 1, 1998

Clinical and Economic Considerations of Antimicrobial Use
Volume 4
Issue 11 Suppl

CME Quiz

Articles in this issue

over 27 years ago

Article

Optimizing Antimicrobial Therapy and Emerging Pathogens

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction

over 27 years ago

Article

Mechanisms and Current Rates of Resistance

over 27 years ago

Article

Influence of Antibiotics on the Normal Flora

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: General Overview

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: Pediatric Issues

over 27 years ago

Article

Pharmacoeconomic Impact of Appropriate Clinical Pathways

over 27 years ago

Article

Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

over 27 years ago

Article

Developing Cost-Effective Guidelines for the Appropriate Use of Antimicrobial Therapy in Respiratory Tract Infection

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

CME Quiz

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

COVID Postexposure Prophylaxis Expands Prevention Toolkit: Noah Greenspan, DPT, PT